282 related articles for article (PubMed ID: 22194627)
1. COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing.
Milbury CA; Correll M; Quackenbush J; Rubio R; Makrigiorgos GM
Clin Chem; 2012 Mar; 58(3):580-9. PubMed ID: 22194627
[TBL] [Abstract][Full Text] [Related]
2. Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.
Castellanos-Rizaldos E; Liu P; Milbury CA; Guha M; Brisci A; Cremonesi L; Ferrari M; Mamon H; Makrigiorgos GM
Clin Chem; 2012 Jul; 58(7):1130-8. PubMed ID: 22587896
[TBL] [Abstract][Full Text] [Related]
3. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations.
Milbury CA; Li J; Makrigiorgos GM
Clin Chem; 2009 Dec; 55(12):2130-43. PubMed ID: 19815609
[TBL] [Abstract][Full Text] [Related]
4. Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.
Li J; Milbury CA; Li C; Makrigiorgos GM
Hum Mutat; 2009 Nov; 30(11):1583-90. PubMed ID: 19760750
[TBL] [Abstract][Full Text] [Related]
5. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
[TBL] [Abstract][Full Text] [Related]
6. Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.
Oezkan F; Herold T; Darwiche K; Eberhardt WEE; Worm K; Christoph DC; Wiesweg M; Freitag L; Schmid KW; Theegarten D; Hager T; Koenig MJ; He K; Taube C; Schuler M; Breitenbuecher F
Clin Lung Cancer; 2018 Nov; 19(6):e879-e884. PubMed ID: 30206042
[TBL] [Abstract][Full Text] [Related]
7. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
8. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing.
Li J; Wang L; Mamon H; Kulke MH; Berbeco R; Makrigiorgos GM
Nat Med; 2008 May; 14(5):579-84. PubMed ID: 18408729
[TBL] [Abstract][Full Text] [Related]
9. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
[TBL] [Abstract][Full Text] [Related]
10. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.
Kristensen LS; Daugaard IL; Christensen M; Hamilton-Dutoit S; Hager H; Hansen LL
Hum Mutat; 2010 Dec; 31(12):1366-73. PubMed ID: 20848649
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
Araki T; Shimizu K; Nakamura K; Nakamura T; Mitani Y; Obayashi K; Fujita Y; Kakegawa S; Miyamae Y; Kaira K; Ishidao T; Lezhava A; Hayashizaki Y; Takeyoshi I; Yamamoto K
J Mol Diagn; 2010 Jan; 12(1):118-24. PubMed ID: 20007840
[TBL] [Abstract][Full Text] [Related]
13. Application of COLD-PCR for improved detection of KRAS mutations in clinical samples.
Zuo Z; Chen SS; Chandra PK; Galbincea JM; Soape M; Doan S; Barkoh BA; Koeppen H; Medeiros LJ; Luthra R
Mod Pathol; 2009 Aug; 22(8):1023-31. PubMed ID: 19430420
[TBL] [Abstract][Full Text] [Related]
14. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.
Kristensen LS; Andersen GB; Hager H; Hansen LL
Hum Mutat; 2012 Jan; 33(1):264-71. PubMed ID: 21901793
[TBL] [Abstract][Full Text] [Related]
15. Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.
Santis G; Angell R; Nickless G; Quinn A; Herbert A; Cane P; Spicer J; Breen R; McLean E; Tobal K
PLoS One; 2011; 6(9):e25191. PubMed ID: 21949883
[TBL] [Abstract][Full Text] [Related]
16. Rapid and sensitive detection of KRAS mutation after fast-COLD-PCR enrichment and high-resolution melting analysis.
Song C; Milbury CA; Li J; Liu P; Zhao M; Makrigiorgos GM
Diagn Mol Pathol; 2011 Jun; 20(2):81-9. PubMed ID: 21532494
[TBL] [Abstract][Full Text] [Related]
17. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.
Li J; Wang L; Jänne PA; Makrigiorgos GM
Clin Chem; 2009 Apr; 55(4):748-56. PubMed ID: 19233916
[TBL] [Abstract][Full Text] [Related]
18. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population.
Fakhruddin N; Mahfouz R; Farhat F; Tfayli A; Abdelkhalik R; Jabbour M; Yehia L; Mahfoud Z; Zaatari G
Oncol Rep; 2014 Nov; 32(5):2223-9. PubMed ID: 25120214
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies.
Freidin MB; Freydina DV; Leung M; Montero Fernandez A; Nicholson AG; Lim E
Clin Chem; 2015 Oct; 61(10):1299-304. PubMed ID: 26272233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
